TSE:NVC - Neovasc Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
C$1.78 +0.04 (+2.30 %)
(As of 10/23/2018 04:00 PM ET)
Previous CloseC$1.74
Today's RangeC$1.76 - C$1.82
52-Week RangeC$0.49 - C$6.07
Volume46,869 shs
Average Volume111,876 shs
Market CapitalizationC$25.23 million
P/E RatioN/A
Dividend YieldN/A
Beta1.04
Neovasc Inc. (Neovasc) is a specialty medical device company. The Company develops, manufactures and markets products for the cardiovascular marketplace. The Company's segment is the development, manufacture and marketing of medical devices. Its products include the Tiara technology in development for the transcatheter treatment of mitral valve disease, the Neovasc Reducer for the treatment of refractory angina, and tissue products. The Tiara is in preclinical/early clinical stage development to provide a minimally invasive transcatheter device for patients experiencing mitral regurgitation (MR) as a result of mitral heart valve disease. The Reducer is an hourglass-shaped, balloon-expandable, stainless steel, bare metal device, which is implanted in the coronary sinus, creating a restriction in venous outflow from the myocardium (the muscular layer of the heart wall). Neovasc produces Peripatch, a biological tissue product that is manufactured from pericardium.

Receive NVC News and Ratings via Email

Sign-up to receive the latest news and ratings for NVC and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange TSE
Industry N/A
Sub-IndustryN/A
SectorN/A
Current SymbolTSE:NVC
Previous Symbol
CUSIPN/A
Phone+1-604-2704344

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net Margins-341.55%
Return on EquityN/A
Return on Assets-22.34%

Miscellaneous

EmployeesN/A
Outstanding Shares78,683,000
Market CapC$25.23 million
OptionableN/A

Neovasc (TSE:NVC) Frequently Asked Questions

What is Neovasc's stock symbol?

Neovasc trades on the Toronto Stock Exchange (TSX) under the ticker symbol "NVC."

When is Neovasc's next earnings date?

Neovasc is scheduled to release their next quarterly earnings announcement on Tuesday, November 13th 2018. View Earnings Estimates for Neovasc.

Who are Neovasc's key executives?

Neovasc's management team includes the folowing people:
  • Paul L. Geyer, Independent Chairman of the Board
  • Fred Colen, President, Chief Executive Officer
  • Christopher Clark, Chief Financial Officer, Corporate Secretary
  • Brian McPherson, Chief Operating Officer
  • Vicki Lee Bebeau, Vice President - Clinical Affairs
  • Randy Lane, Vice President - Research & Development
  • Alexei J. Marko, Director
  • Jane H. Hsiao Ph.D., Independent Director (Age 69)
  • Douglas Glen Janzen, Independent Director
  • William O'Neill, Independent Director (Age 61)

How do I buy shares of Neovasc?

Shares of NVC and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.

What is Neovasc's stock price today?

One share of NVC stock can currently be purchased for approximately C$1.78.

How big of a company is Neovasc?

Neovasc has a market capitalization of C$25.23 million.

What is Neovasc's official website?

The official website for Neovasc is http://www.neovasc.com/.

How can I contact Neovasc?

Neovasc's mailing address is 13562 Maycrest Way Suite 5138, RICHMOND, BC V6V 2J7, Canada. The company can be reached via phone at +1-604-2704344.


MarketBeat Community Rating for Neovasc (TSE NVC)

Community Ranking:  3.0 out of 5 (star star star)
Outperform Votes:  57 (Vote Outperform)
Underperform Votes:  38 (Vote Underperform)
Total Votes:  95
MarketBeat's community ratings are surveys of what our community members think about Neovasc and other stocks. Vote "Outperform" if you believe NVC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NVC will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 10/23/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel